Labeler
LEO Pharma Inc. NDC Codes
LEO Pharma Inc. lists 9 finished drug products in the FDA NDC Directory under NDC labeler code 50222.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Active ingredients
- Spesolimab, Tralokinumab, Betamethasone dipropionate, Delgocitinib, Azelaic acid, Calcipotriene monohydrate, Calcipotriene hydrate
- NDC labeler codes
- 50222
- Strengths
- Betamethasone dipropionate .5 mg/g; Spesolimab 60 mg/mL; Spesolimab 150 mg/mL; Spesolimab 300 mg/2mL; Delgocitinib 20 mg/g; Tralokinumab 300 mg/2mL; Tralokinumab 150 mg/mL; Azelaic acid .15 g/g; Calcipotriene monohydrate 50 ug/g; Calcipotriene hydrate 50 ug/g
- Dosage forms
- Injection, Injection, Solution, Aerosol, Foam, Cream, Suspension
- Routes
- Subcutaneous, Topical
- Drug classes (FDA established)
- Interleukin-36 Receptor Antagonist, Interleukin-13 Antagonist, Corticosteroid, Vitamin D Analog, Janus Kinase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 20
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Spevigospesolimab | Spesolimab 60 mg/mL | InjectionSubcutaneous | 50222-360 | 50222-0360-72 | — |
| Spevigospesolimab | Spesolimab 150 mg/mL | InjectionSubcutaneous | 50222-361 | 50222-0361-02 | — |
| Spevigospesolimab | Spesolimab 300 mg/2mL | InjectionSubcutaneous | 50222-362 | 50222-0362-0150222-0362-02 | — |
| Anzupgodelgocitinib | Delgocitinib 20 mg/g | CreamTopical | 50222-280 | 50222-0280-3050222-0280-9150222-0280-99 | — |
| Adbrytralokinumab-ldrm | Tralokinumab 300 mg/2mL | Injection, SolutionSubcutaneous | 50222-350 | 50222-0350-0150222-0350-0250222-0350-91 | — |
| Adbrytralokinumab-ldrm | Tralokinumab 150 mg/mL | Injection, SolutionSubcutaneous | 50222-346 | 50222-0346-0250222-0346-0450222-0346-92 | — |
| Finacea Foamazelaic acid | Azelaic acid .15 g/g | Aerosol, FoamTopical | 50222-303 | 50222-0303-5050222-0303-91 | — |
| Enstilarcalcipotriene and betamethasone dipropionate | Calcipotriene monohydrate 50 ug/g; Betamethasone dipropionate .5 mg/g | Aerosol, FoamTopical | 50222-302 | 50222-0302-6050222-0302-6650222-0302-91 | — |
| Taclonexcalcipotriene and betamethasone dipropionate | Calcipotriene hydrate 50 ug/g; Betamethasone dipropionate .5 mg/g | SuspensionTopical | 50222-501 | 50222-0501-0650222-0501-66 | — |
LEO Pharma Inc.: common questions
- What is LEO Pharma Inc.'s NDC labeler code?
- 50222. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for LEO Pharma Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.